Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdita Food Regs Regulatory News (EFID)

  • There is currently no data for EFID

EGM invitation

31 Oct 2023 10:55

RNS Number : 8801R
Edita Food Industries S.A.E.
31 October 2023
 

 

 

 

 

Edita Food Industries - Invitation of Extraordinary General Assembly Meeting

 

The Chairman of the Board of Directors of Edita Food Industries S.A.E. ("the Company"), has the pleasure to invite the shareholders of the Company to attend the Extraordinary General Assembly Meeting of the Company set to convene on 26 November 2023 at 3:00 p.m. through the E-MAGLES system, where the shareholders would be able to remotely vote electronically vote on all items of the agenda, and to attend the meeting through video call, which is deemed valid attendance to the meeting. Shareholders shall register and complete all data through the following QR Code:

 

 

 

 

 

 

 

 

 

 

 

rebrand.ly/Edita

 

 

 

To discuss the set forth agenda:

 

1. Discussing the approval of the amendment of the objective of the company and accordingly the amendment of Article (3) of the company's articles of association.

 

2. Discussing the approval of the reduction of the capital of the Company by way of Cancelling treasury shares of the company.

 

3. Discussing the approval of the amendment of Articles (6) and (7) of the articles of association of the Company.

 

We draw the attention of the shareholders to the following:

 

· Each shareholder shall be entitled to attend the extraordinary general meeting in person or by proxy to another shareholder who is not a board member, by virtue of a written power of attorney.

· No shareholder may represent more than 10% of the issued share capital of the Company by proxy at the extraordinary general meeting, and not exceeding 20% of the shares represented at the meeting.

 

· Shareholders wishing to attend the extraordinary general meeting must submit an evidence that they have deposited their shares at the Company's headquarters, at a certified bank or a financial entity which is licensed by the Financial Regulatory Authority or submit a statement issued by a central custodian or Misr for Central Clearing, Depository and Registry stating that the shares have been frozen for purposes of attending the meeting and until its adjournment. The shares may not be withdrawn until the end of the extraordinary general assembly meeting.

 

· The extraordinary general meeting shall be valid if attended by shareholders representing at least 50% of the issued share capital. If the quorum not attained at the meeting, a second meeting shall convene the following day at the same time and with the same mechanism set for the first meeting specified in the invitation, and the second meeting shall be deemed valid if attended by shareholders representing at least 25% of the issued share capital of the company.

 

· Resolutions of the extraordinary general meeting shall be adopted by a majority of three quarters of the shares represented.

 

· Any inquiries relating to the agenda of the extraordinary general meeting shall be delivered in writing by registered mail or hand delivered at the Company's headquarters at least three days prior to the extraordinary general meeting.

 

· All documents to be made available to shareholders in accordance with Article 221/228 of the Executive Regulations of the Companies Law No. 159 of 1981 are available for review at the Company's headquarters located at Shaikh Zayed City - Sixth of October - Plot No. (13) - Central Pivot - Giza, during official working hours.

 

Please note that electronic voting on all items of the agenda of the extraordinary general assembly meeting will be open and all shareholders must follow the procedures prescribed in the system for the electronic registration and voting through the above QR Code.

 

The attached invitation in Arabic will be published in two daily newspapers.

 

Eng. Hani Berzi

 Chairman

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRNKDBPKBDDDKN
Date   Source Headline
2nd Nov 20213:45 pmRNSEdita's Results- 3Q2021
2nd Nov 20213:41 pmRNSEdita's Board Resolution- 3Q2021
1st Nov 20217:00 amRNSTwinkies higher price point introduction at EGP3
25th Oct 202110:12 amRNSEdita raises price points across Molto products
2nd Aug 20212:32 pmRNSEdita's Summary of Board Resolutions- 2Q2021
2nd Aug 20212:26 pmRNSEdita Announces 2Q2021/1H2021 Results
10th May 20212:19 pmRNS1Q2021 Financial Statements & Earnings Release
10th May 20212:02 pmRNSResolutions of BoD Meeting 10 May 2021
7th Apr 20218:18 amRNSAnnouncement on Dividend Distribution
6th Apr 20217:00 amRNSEdita's EGM Summary of Resolutions
1st Apr 20213:00 pmRNSEdita's EGM invitation
31st Mar 20218:43 amRNSSummary of Resolutions of OGM, 30 March 2021
30th Mar 20217:00 amRNSEdita signs a new medium term loan
11th Mar 20217:46 amRNSEdita's EGM Invitation
8th Mar 20218:28 amRNSEdita's OGM Invitation
24th Feb 20213:23 pmRNSEdita Food Industries Reports FY2020 Earnings
24th Feb 20213:00 pmRNSSummary of BoD Resolutions 24 Feb. 2021
8th Feb 20217:00 amRNSEdita installs new wafer line
31st Dec 202012:40 pmRNSSecond Price Monitoring Extn
31st Dec 202012:35 pmRNSPrice Monitoring Extension
10th Nov 20202:32 pmRNSEdita 3Q2020 Financial Results & Earnings Release
10th Nov 20202:28 pmRNSBoard of directors decisions 10 November 2020
13th Oct 20209:50 amRNSDisclosure regarding a dispute
22nd Sep 20208:43 amRNSLoan announcement
28th Jul 20203:45 pmRNSEdita 2Q2020 Financial Results
28th Jul 20203:42 pmRNSEdita Board of Directors meeting 28July20
29th Jun 20201:42 pmRNSMorocco Loan Announcement
4th Jun 20202:14 pmRNSTreasury Shares program
20th May 20208:49 amRNSEdita Enters the Biscuits Segment
12th May 20209:27 amRNSEdita's 1Q2020 Earnings Release
12th May 20209:14 amRNSResolutions of BoD Meeting on May 11
22nd Apr 202012:07 pmRNSSecond Price Monitoring Extn
22nd Apr 202012:02 pmRNSPrice Monitoring Extension
7th Apr 20208:45 amRNSAnnouncement on Dividend Distribution
6th Apr 20201:08 pmRNSResolutions of BoD meeting 5th of April
6th Apr 20207:00 amRNSLoan Announcement
31st Mar 202010:31 amRNSAGM Statement
26th Mar 20208:41 amRNSAudited Consolidated IFRS Statements 2019
5th Mar 20208:16 amRNSEdita OGM invitation
27th Feb 20207:20 amRNSBoard of Directors meeting decisions 26 feb 2020
26th Feb 20205:02 pmRNSEdita Earnings Release 2019
26th Feb 20204:52 pmRNSIFRS Financial Statements 2019
26th Feb 20204:15 pmRNSEdita Financial Results
26th Feb 20203:18 pmRNSBoard of Directors meeting decisions 26 Feb 2020
30th Oct 20192:50 pmRNSEdita 3Q2019 Edita financial Results
30th Oct 20192:15 pmRNSBoard of Directors change
30th Oct 20192:07 pmRNSEdita BOD decisions 30 October 2019
21st Oct 20197:00 amRNSEdita receives a MAD15million grant
30th Jul 20195:08 pmRNS2Q2019 Audited Financial Results
30th Jul 20194:55 pmRNSBoard of directors decisions 30 July 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.